Apoptosis induced by extracellular glutathione is mediated by H2O2 production and DNA damage

International Journal of Cancer

Volumn 87, Issue 3, 2000, Pages 343-348

  Perego, Paola ^a   Gatti, Laura ^a   Carenini, Nives ^a   Dal Bo, Laura ^a   Zunino, Franco ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; DNA; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; PROTEIN P21; PROTEIN P53;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOTOXICITY; DNA DAMAGE; DNA STRAND BREAKAGE; ENZYME DEGRADATION; GENOTOXICITY; HUMAN; HUMAN CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN INDUCTION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CYCLE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DNA, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; GLUTATHIONE; GROWTH INHIBITORS; HUMANS; HYDROGEN PEROXIDE; METABOLIC DETOXICATION, DRUG; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; OXIDATIVE STRESS; POLY(ADP-RIBOSE) POLYMERASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034255749     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000801)87:3<343::AID-IJC6>3.0.CO;2-8     Document Type: Article

References (20)

1. AGARWAL, M.L., TAYLOR, W.R., CHERNOV, M.V., CHERNOVA, O.B. and STARK, G.R., The p53 network. J. Biol. Chem., 273(1), 1-4 (1998).
2. 2 block induced by DNA damage: a caffeine-resistant component independent of Cdc25C, MPM-2 phosphorylation, and H1 kinase activity. Cancer Res., 58, 2639-2645 (1998).
3. CLUTTON, S. The importance of oxidative stress in apoptosis. Brit. Med. Bull., 53, 662-668 (1997).
4. Di RE, F., BOHM, S., ORIANA, S., SPATTI, G.B., PIROVANO, C., TEDESCHI, M. and ZUNINO, F., High-dose cisplatin and cyclophosphamide with glutathione in the treatment of advanced ovarian cancer. Ann. Oncol., 4, 55-61 (1993).
5. HAMERS, F.P.T., BRAKKEE, J.H., CAVALLETTI, E., TEDESCHI, M., MARMONTI, L., PEZZONI, G., NEIJT, J.P. and GISPEN, W.H., Reduced glutathione protects against cisplatin-induced neurotoxicity in rats. Cancer Res., 53, 544-549 (1993).
6. HOCKENBERY, D.M., OLTVAI, Z.N., YIN, X.-M., MILLIMAN, C.L. and KORSMEYER, S.J., Bcl-2 functions in an anti-oxidant pathway to prevent apoptosis. Cell, 75, 241-251 (1993).
7. KARMALI, R.A., Growth inhibition and prostaglandin metabolism in the R3230AC mammary adenocarcinoma by reduced glutathione. Cancer Biochem. Biophys., 7, 147-154 (1984).
8. KAUFMANN, S.H., DESNOYERS, S., OTTAVIANO, Y., DAVIDSON, N.E. and POIRIER, G.G., Specific proteolytic cleavage of poly(ADP-ribose)polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res., 53, 3976-3985 (1993).
9. KOHN, R.W., EWIG, R.A.G., ERICKSON, L.C. and ZWELLING, L.A., Measurements of strand breaks and cross-links by alkaline elution. In: Friedberg E.C. and Hanawalt P.C. (eds.), DNA repair. A laboratory manual of research procedures. Vol. 1, part B, pp. 370-401, Marcel Dekker, New York (1981).
10. MEISTER, A., Glutathione, ascorbate and cellular protection. Cancer Res., 54, 1969s-1975s (1994).
11. PEREGO, P., GIAROLA, M., RIGHETTI, S.C., SUPINO, R., CASERINI, C., DELIA, D., PIEROTTI, M.A., MIYASHITA, T., REED, J.C. and ZUNINO, F., Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems. Cancer Res., 56, 556-562 (1996).
12. PEREGO, P., PAOLICCHI, A., TONGIANI, R., POMPELLA, A., TONARELLI, P., CARENINI, N., ROMANELLI, S. and ZUNINO, F., The cell-specific anti-proliferative effect of reduced glutathione is mediated by γ-glutamyl transpeptidase-dependent extracellular pro-oxidant reactions. Int. J. Cancer, 71, 246-250 (1997a).
13. PEREGO, P., RIGHETTI, S.C., SUPINO, R., DELIA, D., CASERINI, C., CARENINI, N., BEDOGNÉ, B., BROOME, E., KRAJEWSKI, S., REED, J.C. and ZUNINO, F., Role of apoptosis-related proteins in the cisplatin-resistant phenotype of human tumor cell lines. Apoptosis. 2, 540-548 (1997b).
14. PEREGO, P., ROMANELLI, S., CARENINI, N., MAGNAM, I., LEONE, R., BONETTI, A., PAOLICCHI, A. and ZUNINO F., Ovarian cancer cisplatin-resistant cell lines: multiple changes including collateral sensitivity to taxol. Ann. Oncol., 9, 423-430 (1998).
15. POLYAK, K., XIA, Y., ZWEIER, J.L., KINZLER, K.W. and VOGELSTEIN, B., A MODEL FOR p53-INDUCED APOPTOSIS. Nature, 389, 300-305 (1997).
16. SESTILI, P., CATTABENI, F. and CANTONI, O., The induction/loss of the oxidant-resistant phenotype of Chinese hamster ovary (CHO) cell variants does not correlate with sensitivity to DNA single strand breakage by hydrogen peroxide. Biochem. Pharmacol., 48, 1701-176 (1994).
17. STARK, A.-A., PAGANO, D.A., GLASS, G., KAMIN-BELSKY, N. and ZEIGER, E., The effects of anti-oxidants and enzymes involved in glutathione metabolism on mutagenesis by glutathione and L-cysteine. Mutat. Res., 308, 215-222 (1994).
18. VON REIN, C. and HIRSCHELMANN, R., Comparison of a fluorimetric and a colorimetric method for the determination of hydrogen peroxide production by rat pleural macrophages. J. Pharmacol. Methods, 26, 61-65 (1991).
19. ZUNINO, F., DE CESARE, M., ORIANA, S., PEREGO, P., PASINI, A. and TEDESCHI, M., The role of GSH in cisplatin therapy. Proceedings of the First European Workshop on Glutathione. Bull. Soc. Luxemb. Biol. Clin., (special issue), 121-132 (1993).
20. ZUNINO, F., PRATESI, G., MICHELONI, A., CAVALLETTI, E., SALA, F. and TOFANETTI, O., Protective effect of reduced glutathione against cisplatin-induced renal and systemic toxicity and its influence on the therapeutic activity of the anti-tumor drug. Chem.-Biol. Interact., 70, 89-101 (1989).